Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
8.115 USD | -2.46% | -9.83% | -0.18% |
Jun. 01 | Transcript : Iovance Biotherapeutics, Inc. - Special Call | |
May. 13 | Truist Securities Trims Iovance Biotherapeutics' Price Target to $25 From $26, Buy Rating Maintained | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-0.18% | 2.33B | |
-39.47% | 8.41B | |
+10.35% | 3.82B | |
-21.06% | 2.02B | |
-21.37% | 1.67B | |
+29.31% | 1.14B | |
+27.75% | 760M | |
-9.39% | 697M | |
-21.33% | 566M | |
-1.29% | 290M |
- Stock Market
- Equities
- IOVA Stock
- News Iovance Biotherapeutics, Inc.
- Piper Sandler Adjusts Iovance Biotherapeutics Price Target to $19 From $18, Maintains Overweight Rating